Refresh

Paul Merchants Ltd.

Price on BSE   26 Feb,15:06 LIVE
516.00
+1.75
(+0.34%)

© 2026 Rediff.com
  • Volume :
  • 764.00
  • Prev Close :
  • 514.25
  • Day's H/L (Rs.) :
  • 526.00 - 500.00
  • 52wk H/L (Rs.) :
  • 840.00 - 505.10
  • Mkt Cap (Rs. Cr) :
  • 159.97
Paul Merchants Ltd. is not listed on NSE

© 2026 Rediff.com
Report Card - Paul Merchants Ltd.
PE Ratios
27.36
EPS (Rs.)
19.16
Sales (Rs. Cr)
499.61
Face Value (Rs.)
10
Net Profit Margin(%)
0.17
Last Bonus
2:1
Last Dividend(%)
20
Return on Average Equity
1.22

News for Paul Merchants Ltd.

L&T Finance Q4 Profit Rises 15% to Rs 636 Crore
L&T Finance Holdings reported a 15% rise in consolidated net profit to Rs 636 crore for the January-March quarter of 2024-25. The company's total income also increased during the...
Apr 25, 2025 21:33

More News for Paul Merchants Ltd. »

News for Miscellaneous

Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48
India Trade Policy Review at WTO in July 2026
India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.
Feb 26, 2026 14:33
Swiggy & IRCTC: Food on Train Expands to 152 Stations
Swiggy and IRCTC expand 'Food on Train' service to 152 stations across India. Holi special menu & train-friendly dishes launched.
Feb 26, 2026 14:25

More News »

Top News

Alembic Pharma Gets USFDA Nod for Generic Drug
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Feb 26, 2026 14:51
Acerpure Eyes Emerging Markets After India Success
Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.
Feb 26, 2026 14:49
Gushwork AI Raises Rs 81 Cr Funding
Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.
Feb 26, 2026 14:48
Cytiva Expands Bengaluru Fast Trak Facility
Cytiva expands its Fast Trak process development facility in Bengaluru to support biopharma companies in India and Asia-Pacific.
Feb 26, 2026 14:48
India Trade Policy Review at WTO in July 2026
India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.
Feb 26, 2026 14:33

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com